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Purpose: Intrafraction motion during step-and-shoot (SNS) IMRT is known to affect the target dosimetry by a
combination of dose blurring and interplay effects. These effects are typically managed by adding a margin around
the target. A quantitative analysis was performed, assessing the relationship between target motion, margin size,
and target dosimetry with the goal of introducing new margin recipes.
Methods: A computational algorithm was used to calculate 1,174 motion-encoded dose distributions and DVHs
within the patient’s CT dataset. Sinusoidal motion tracks were used simulating intrafraction motion for nine lung
tumor patients, each with multiple margin sizes.
Results: D95% decreased by less than 3% when the maximum target displacement beyond the margin experienced
motion less than 5 mm in the superior-inferior direction and 15 mm in the anterior-posterior direction. For target
displacements greater than this, D95% decreased rapidly.
Conclusions: Targets moving in excess of 5 mm outside the margin can cause significant changes to the target.
D95% decreased by up to 20% with target motion 10 mm outside the margin, with underdosing primarily limited to
the target periphery. Multi-fractionated treatments were found to exacerbate target under-coverage. Margins several
millimeters smaller than the maximum target displacement provided acceptable motion protection, while also allowing
for reduced normal tissue morbidity.
Keywords: IMRT, Motion, Step-and-shoot, Lung, Dosimetry
PACS: 87.55.dkIntroduction
During radiation therapy, intrafraction motion has the po-
tential to affect target dosimetry [1], sometimes with signifi-
cant consequences to target dose coverage [2,3]. This is
especially true during intensity modulated radiation therapy
(IMRT) [4], where increases in target conformality can pro-
duce more desirable dose distributions for the static patient,
but at the same time can make the target more susceptible
to underdose due to intrafraction target motion [5]. A num-
ber of techniques exist to minimize the effects of intrafrac-
tion motion, with the addition of a planning target volume
(PTV) being the most commonly used technique to main-
tain uniform dosimetry to the target even during motion [6].
Several methods have been developed to estimate the
dosimetric impact of intrafraction motion including Monte* Correspondence: amish.shah@orlandohealth.com
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reproduction in any medium, provided the orCarlo simulations [7], experimental phantom measurements
[8,9] and computational methods [10-12]. One recent com-
putational technique applied a given motion track to a
static treatment plan to estimate the three-dimensional
(3D) dose distribution within the patient anatomy, allow-
ing for performance of DVH-based analyses [10]. This
current study utilizes the same technique to investigate
the impact of intrafraction motion on SNS IMRT, spe-
cifically to study the relationship between motion and
dosimetric effect. Motion and planning parameters were
varied to test a range of combinations, some of which
were similar to those used clinically while others were, by
design, beyond those used clinically. The CT dataset and
target contours from nine lung cancer patients were inves-
tigated, encompassing a representative range of tumor
shapes and sizes. In total 1,174 motion-encoded dose dis-
tributions were calculated for different sinusoidal motion
track, margin size, and treatment plan combinations foral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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multi-fractionated deliveries were also considered.
Methods and materials
Under an Institutional Review Board (IRB)-approved pro-
tocol, nine lung cancer cases were retrospectively reviewed
for this motion study, all of which had been selected for 6
MV SNS IMRT treatments.
Treatment planning
The initial target volume determination for the nine patients
were contoured by a radiation oncologist using information
from the individual 4DCT phases, the average CT, and the
maximum intensity projection (MIP) reconstruction from
the 4DCT, resulting in volumes ranging from 22.2 to
503.1 cm3 (average volume ± 1 standard deviation = 228.9 ±
185.4 cm3). Target and PTV combinations with target to
PTV margin expansions of 0, 3, 6, 10 and 15 mm were
uniformly applied. Clinically relevant optimization objectives
were used to create SNS IMRT treatment plans for each
PTV/target combination within a research version of a com-
mercial treatment planning system (Pinnacle, Version 8.1x,
Philips Healthcare, Andover, MA). The treatment plans
were calculated on the patient’s free-breathing CT. The
number of beams (all coplanar), treatment prescription,
average number of segments per beam, and the average
patient plan MU/dose (assumed to be proportional to the
plan complexity [13]) are summarized in Table 1.
Calculating the motion-encoded dose distribution
A computational algorithm was developed in MATLAB to
estimate the dosimetric effect of intrafraction motion [10].
Based upon a chosen motion track, individual segment flu-
ence maps were shifted in the opposite direction of the
physical target’s beams-eye-view displacement in order to
account for this motion during each delivered monitor unit
(MU). MU timing was calculated using a 400 MU/minute
dose rate, assuming a 1 second interval between each seg-









1 7,000 35 8 22
2 7,000 35 6 25
3 4,500 30 6 47
4 7,000 35 9 50
5 7,400 37 6 32
6 7,000 35 6 23
7 6,000 30 8 99
8 5,000 20 5 74
9 7,400 37 11 29DynaLog files) and a 40 second interval between each
gantry angle. A final dose calcula-tion was performed
within the CT dataset using the modified fluence maps,
creating the 3D motion-encoded dose distribution. Previous
work has validated the accuracy of the motion-encoded
dose distributions [10].
Motion tracks
Ideally, this analysis would be performed using clinically
acquired tumor motion tracks. It has been demonstrated,
however, that respiratory motion can be approximated as
sinusoidal motion of the form shown in Eq. 1 [14]:
Displacement tð Þ mm½  ¼ A mm½ ⋅ sin

2π
T sec½  t sec½  þ φ

þ D mm= sec½ ⋅ t sec½ ð Þ þO mm½ 
ð1Þ
Each parameter from Eq. 1 (namely amplitude (A, half
peak-to-peak motion), drift (D), offset (O), period (T) and
phase (φ)) was investigated separately to determine its effect
on the dosimetry. The specific motion variables for each
patient are shown in Table 2, with default values of A =
7.2 mm, T = 3.8 sec [14], φ = 0°, D = 0 mm/min and O=
0 mm being used when not being explicitly stated. For ex-
ample, when the effect of target drift was being investigated,
values of A = 7.2 mm, T = 3.8 sec, φ = 0° and O= 0 mm
were held constant while the drift rate was varied as shown
in Table 2, column 4. For each motion track, data was
calculated for every margin size listed in Table 1, creating
a total of 1,174 motion-encoded dose distributions.
Intrafraction motion dosimetric impact analysis
Motion-encoded target DVHs were calculated from the
motion-encoded dose distribution, and were compared
to the static DVHs by calculating target ΔD95% and ΔD05%
values; these represent the difference between static
and motion-encoded D95% and D05%, respectively. By
definition, ΔD95% and ΔD05% equal unity if the motion had








.2 0,3,6,10 & 15 4.0 2.31
.9 0,3,6,10 & 15 3.9 2.06
6.5 0,3,6 & 10 7.8 3.37
3.1 0,3,6 & 10 9.2 3.33
5.4 0,3,6 & 10 10.0 2.29
8.5 0,3,6 & 10 11.5 2.54
.2 0,3,6 & 10 8.3 2.56
.4 0,3,6 & 10 9.6 1.70
4.9 0,3,6 & 10 6.4 3.29
Table 2 Motion track parameters per patient
Patient number Motion direction Amplitude
(half peak-to-peak, mm)
Drift (mm/min) Offset (mm) Period (sec) Phase (radians)
1 SI/AP/3D 0, 3, 5, 7.2, 10, 15 −3, −1.6, 0, 1.6, 3 −3, −2, −1, 0, 1, 2, 3 2.2, 3.8, 6.4, 10 0, 2π/5, 4π/5, 6π/5, 8π/5
2 SI/AP/3D 0, 3, 5, 7.2, 10, 15 −3, −1.6, 0, 1.6, 3 −3, −2, −1, 0, 1, 2, 3 2.2, 3.8, 6.4, 10 0, 2π/5, 4π/5, 6π/5, 8π/5
3 SI/AP 0, 5, 7.2, 10, 15 −2, 0, 2 0, 3, 5 3.8 0
4 SI/AP 0, 5, 7.2, 10, 15 −2, 0, 2 0, 3, 5 3.8 0
5 SI/AP 0, 5, 7.2, 10, 15 −2, 0, 2 0, 3, 5 3.8 0
6 SI/AP 0, 5, 7.2, 10, 15 −2, 0, 2 0, 3, 5 3.8 0
7 SI/AP 0, 5, 7.2, 10, 15 −2, 0, 2 0, 3, 5 3.8 0
8 SI/AP 0, 5, 7.2, 10, 15 −2, 0, 2 0, 3, 5 3.8 0
9 SI/AP 0, 5, 7.2, 10, 15 −2, 0, 2 0, 3, 5 3.8 0
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calculated for each motion calculation and represents
the maximum displacement of the target outside the PTV
(Figure 1). This parameter was used to assess the effective-
ness of the margin concept for motion management, with
an acceptable target deviation selected as ΔD95% > 0.97
(i.e. less than a 3% reduction in D95%). The study was
designed to provide a wide range of sinusoidal tumor
displacements, encompassing a majority of the maximum
tumor displacement expected clinically. Therefore, ana-
lysis of the ‘Max Displacement – Margin’ parameter was
used to create a new approach to the margin size decision
making process.Multi-fractionation analysis
To determine the cumulative impact of motion on mul-
tiple fractions, accumulated DVHs were calculated for the
following scenarios:Figure 1 A schematic representation of intrafraction target motion.1) Patient 2 (0 mm margin), five fractions each with
the same target motion track (15 mm amplitude SI),
but with different starting phases.
2) Patient 5 (0 mm margin), with seven randomly
selected SI motion tracks.
3) Patient 2 (0 mm margin), with thirty randomly
selected SI motion tracks.
Individual fraction motion-encoded dose distributions
and DVHs were calculated, as well as the accumulated
dose distribution and DVH.
Results
The static plan complexity (characterized by the num-
ber of MUs required to deliver a cGy of dose) [13] in-
creased approximately linearly with increasing PTV volume
(Table 1), with the linear least square best fit function
shown in Eq. 2 (r2 = 0.66). Larger PTVs required more
complex static treatment plans (Table 1).
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Two example treatment plans are shown in Figures 2a
and 2b, along with 15 mm amplitude SI motion-encoded
dose distributions in Figures 2c and 2d, respectively. The
corresponding target and PTV DVHs for these two cases
are shown in Figures 2e and 2f.
Motion amplitudes (half peak-to-peak displacement)
used in this study ranged from 0 to 15 mm (Table 2).
These motion tracks corresponded to ‘Max Displace-
ment – Margin’ values ranging from −15 mm (15 mm
margin, 0 mm amplitude) to +15 mm (0 mm margin,
15 mm amplitude). Similarly, drift velocities from −3
to +3 mm/min were investigated with the absolute target
displacement dependent on the treatment time. The aver-
age target displacement due to drift was 9.6 ± 4.8 mm
(‘Max Displacement – Margin’ values ranged from −7.8
to +24.8 mm for the default 7.2 mm amplitude drifting
tracks). Offsets of −3 to +5 mm were also studied (‘Max
Displacement – Margin’ ranged from −7.8 to +12.2 mm
with 7.2 mm amplitude).Figure 2 Dosimetric comparison between patient 7 and patient 4. Sam
(10 mm margin) are shown in a and b, respectively. The dosimetric effect o
for patient 7 and 4, respectively. The corresponding target (thick lines) and
without motion (dashed lines) and with motion (solid lines).Figure 3 shows the effect of ‘Max Displacement –
Margin’ on target D95%, with the results from the ampli-
tude, drift and offset studies shown separately in Figures 3a,
3b and 3c respectively, and combined in 3d. Least-square
fits of a quadratic function were applied to the data for
each test and motion direction (for ‘Max Displacement –
Margin’ values > 0), with the resultant curves shown.
All of the data are included in Figure 3d, ranging from
the motion track with 15 mm margin and 0 mm ampli-
tude motion to the worst-case scenario of zero margin
and 3 mm/min drift. By converting these data points to
‘Max Displacement – Margin’ the full spectrum of motion
tracks studied here can be compared together without
skewing the results; these outliers simply form the ex-
tremes within the plot, and help to define the relationship
between displacement, margin size and target dosimetry.
It can be seen from Figure 3 that the dosimetric effect
of motion is dependent on the direction of motion. For
example, when ‘Max Displacement – Margin’ was between
14 and 16 mm (14.9 ± 0.4 mm), average ΔD95% values for
motion in the AP, SI and 3D directions were 0.97 ± 0.02,
0.90 ± 0.07 and 0.82 ± 0.8 respectively. Using the least-
square best-fit quadratic curves, D95% was reduced byple static treatment plans for patients 7 (6 mm margin) and 4
f a 15 mm amplitude SI sinusoidal motion track is shown in c and d
PTV (thin lines) DVHs for these two cases are shown in e and f, both
Figure 3 The effect of varying the motion amplitude, drift and offset on ΔD95% are shown separately in a, b and c respectively, and
combined in d. Each of the plots shows the effect of increasing the target displacement outside the PTV (‘Max Displacement – Margin’) on target
D95%. The shaded regions represent < ±3% change in D95%. Least-square quadratic fits are shown for each motion direction.
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Margin’ exceeded 15.4, 7.0 and 4.1 mm for motion in
the AP, SI and 3D directions respectively. The shaded
regions in Figure 3 represent a < ±3% change in D95%
due to motion. This data can be directly used as a new
margin recipe, dependent on the direction and magnitude
of the maximum expected tumor displacement.
Changes in target ΔD95% were observed for Patients 1
and 2 with varying periods. ΔD95% values for each indi-
vidual period deviated from the average by only −3.4%
to +1.3%. Similarly, all of the different starting-phase ΔD95%
values for each margin size and motion direction were
within ±1.4% of the average ΔD95% value.
The effect of motion on D05% was also studied, with
only 3.2% of the tracks experiencing more than a 5%
increase in ΔD05%, and less than 1% increasing by more
than 10%. A majority of the high ΔD05% values were
caused by 3D motion with AP motion causing the smallest
changes. Unlike the results for ΔD95%, ΔD05% was rela-
tively independent of the amount of motion present when
the motion size was larger than the margin size.
Figure 4 displays the effect of varying the drift rate
(absolute) on target ΔD95% for various margin sizes in
the SI, AP and 3D directions (Figure 4a, 4b and 4c,
respectively), as well as the effect of increasing the
total SI drift during treatment (Figure 4d). In contrast
to Figure 3, the data shown in Figure 4 distinguishesdirectly between margin size and the drift, as opposed to
combining the variables to form the ‘Max Displacement –
Margin’ quantity. With an amplitude of 7.2 mm present in
each motion track, almost identical motion direction and
margin size dependencies on the target dosimetry are ob-
served, as were seen in Figure 3 and as described above.
Figure 4d also takes into account the total treatment time
by converting the dose rate into the maximum drift dis-
placement (drift rate × treatment time) for each data point.
The maximum total displacement would be the sum-
mation of the total drift and 7.2 mm for the sinusoidal
amplitude. Similar conclusions can be drawn regarding
the effect of margin size on target dosimetry, as described
above.
Finally, the results of the multi-fraction study are shown
in Figure 5. Results from the three different scenarios 1, 2,
and 3 listed above are shown in Figures 5a, 5b, and 5c,
respectively. While the cumulative D95% for multiple
fractions was approximately equal to the average D95%
of the individual fractions, the cumulative D05% was less
than the average D05% of the individual fractions.
Discussion
This investigation was devised to provide a more thorough
understanding of the potentially detrimental dosimetric
effects of intrafraction motion and to investigate the
effectiveness of target margins to minimize these dosimetric
Figure 4 The effect of varying the drift rate on ΔD95% for SI, AP and 3D motions are shown in a, b and c respectively, as well as the
effect of increasing the total SI drift during treatment (d). Each of the plots shows the effect of changing the drift rate of a 7.2 mm amplitude
sinusoidal motion track on target dosimetry for various margin sizes. The shaded regions represent < ±3% change in D95%. Note that the total tumor
displacement is equal to the drift displacement plus the sinusoidal amplitude.
Figure 5 The dosimetric effects of multi-fractionated treatments are shown with DVHs for the static plan (thick dashed line), the
individual fractions (thin lines) and the cumulative dose (thick solid line). a shows five fractions with the same motion track (15 mm
amplitude SI motion), but different starting phases per fraction. b and c show 7 and 30 fractions respectively, with each fraction experiencing a
different, randomly selected, SI motion track.
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moving lung targets has been extensively discussed in the
literature. There are two main thought processes for margin
calculations; (1) include all possible target positions during
the breathing cycle [15] or (2) make a probabilistic margin
calculation based on the target motion [16]. This study pre-
sents a third approach as a compromise between the two
common techniques, as well as provides a simple method
for margin calculation. A range of motion amplitudes and
target margins was investigated, incorporating situations
where the target remained within the PTV during treat-
ment to where the target deviated up to 24.8 mm outside
the PTV. This range was chosen to incorporate the broad
spectrum of tumor motions; for example, although an
upper lobe tumor may move considerably less than a lower
lobe tumor, the smaller displacement data points from this
study can be used for analysis, and vice versa. A relatively
large upper limit of 24.8 mm displacement is useful to
provide a full range of clinically possible motion tracks,
although a tumor with this magnitude of displacement
would most likely use alternative motion management
techniques. In general, changes in D95% were less than 3%
if the margin sizes followed Eq. 3.
Margin Size mmð Þ ≥ Max Displacement mmð Þ ‐ 5 mm
ð3Þ
Based on this investigation, the target can be displaced
by up to 5 mm outside the original PTV with less than
3% change in the target D95%. Additionally, this suggests
that there is little benefit in adding a margin equal to or
greater than the anticipated maximum displacement,
versus a margin that is 5 mm smaller than the extent of
motion. Further, this could potentially improve margin-
size optimization, allowing for better sparing of normal
tissue. Clinically, margins are less likely to be created
isotropically as presented in this study, but typically
might be larger in the craniocaudal plane than the axial
plane, for example. The data presented within this paper
is still valid for anisotropic expansions: the formula pre-
sented in Equation 3 will need to be separated into SI and
AP motion directions to create optimal margin sizes
dependent on the three-dimensional nature of the motion.
Equation 3 is not universally true for all motion tracks
and for all patients; therefore, care has been taken to
study a wide range of different lung tumors in order to
make these conclusions as robust as possible. Additional
studies considering actual patient motion tracks are
warranted to test the integrity of Eq. 3, but are beyond
the scope of this current investigation. Equation 3 provides
a useful guideline for the treatment planning phase of
SNS IMRT under the assumptions that the motion at
time of simulation is the same as the motion at time of
treatment.In Figure 3 it can be seen that the detrimental effects
of motion are strongly dependent on motion direction.
AP motion provides a small reduction in D95%, even
when the maximum target displacement is considerably
larger than the margin size (ΔD95% ≈ 0.97 when the max-
imum target displacement is 15 mm outside the PTV).
SI and 3D motion caused much larger reductions in
D95%. The most likely explanation for this effect is due
to directional differences in dose gradients for co-planar
treatment plans, with a relatively steep dose fall-off out-
side the target volume in the SI direction compared to
AP. Movement of the target through these steep dose
gradients with SI motion would likely cause a greater
dose blurring and therefore a larger reduction in D95%.
Another explanation for the motion-direction depend-
ence occurrence can be realized when considering the
cumulative effect of multiple gantry angles on the inter-
play and dose blurring effects. With zero couch rotation,
SI motion acts perpendicularly to the beam and in the
plane of the MLCs; this increases the contribution of the
interplay effect. Depending on the gantry angle, AP mo-
tion could potentially be moving parallel to the beam
and perpendicular to the MLC plane, eliminating the
interplay effect and reducing intra-fraction motion effects.
In this scenario, the only effect of motion would be an
inverse square correction (which is accounted for in
the algorithm), a small effect compared to a physical
displacement of the target perpendicular to the beam.
With non-coplanar beam configurations, these results
will clearly be different.
Figure 3 demonstrates that the effect of motion on tar-
get dosimetry is dependent on the maximum sinusoidal
target displacement, independent of the type of sinusoidal
motion leading to this maximum (e.g. offset, amplitude or
drift). In other words, Equation 3, and the corresponding
data shown in Figure 3, hold true regardless of whether
the motion tracks creating the displacement were gener-
ated with a drift, offset or variable amplitude. Data from
the independent variable studies are indistinguishable
from each other when plotted in the format shown in
Figure 3d.
The cumulative effect of motion over several fractions
for several different starting phases (Figure 5a) or motion
tracks (Figures 5b and 5c) demonstrated that, while the
cumulative D95% was approximately equal to the average
D95% of the individual fractions, the cumulative D05% was
typically less than that of the individual fractions. The sys-
tematic peripheral cooling effect per fraction is present for
most motion tracks so the cumulative effect of multiple
fractions results in an average under-dosing in these
regions. Conversely however, the more random, smaller
hot spots near the center of the target become less
prominent with increasing fractionation. Other combina-
tions of motion tracks and fractionation schemes were
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to those shown in Figure 5. The data shown in Figure 5
is representative of the observed effects of multiple
treatment fractions, but a more thorough analysis look-
ing into the complex relationships between margins,
drifts and fractionation schemes is beyond the scope of
this current study.Conclusions
Motion-encoded dose distributions were calculated for
multiple sinusoidal motion tracks applied to SNS IMRT
plans for nine lung tumor patients. Further study needs to
be done using actual tumor motion tracks as they become
available. However, the results using these simulated
data provide valuable insight regarding the relationship
between treatment dynamics and tumor motion for SNS
treatments, and also about the protective value of internal
margins. As expected, the addition of an internal margin
around the target forming the PTV reduced the poten-
tially detrimental dosimetric impact of motion. For SI
motion the margin can be reduced by an additional
5 mm while maintaining an acceptable dosimetry in the
target (a change in D95% of less than 3%), allowing for
increased normal tissue sparing. This reduction can be
increased even further for AP motion where SNS IMRT
motion sensitivity appears to be less significant, with a
co-planar beam arrangement. Even in the presence of
moving MLC leafs, data from this investigation suggest
that with careful selection of an internal margin, the dosi-
metric effects of motion can be successfully managed
and the desired dose can be delivered to the target.
Additionally, it was found that clinical target volume
under-coverage due to motion is neither reduced nor
truly propagates as treatment fractionation is increased.Consent
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Health’s institutional review board. It was determined
by the IRB that no consent was necessary, as this study
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